Women in England and Wales denied ‘exciting’ drug that can stop breast cancer spreading

Latest study shows Enhertu, rejected by Nice, can stall growth of tumours by a year, longer than standard chemotherapy

Thousands of women with advanced breast cancer in England and Wales are being denied a drug that cuts the risk of the disease spreading by more than a third.

Enhertu has been rolled out to patients with HER2-low breast cancer in Scotland and Northern Ireland, but the National Institute for Health and Care Excellence (Nice) has rejected it for patients in England. Women in Wales are also being denied the drug.

Continue reading…

11112

450

Subscribe

Connect with

Login

I allow to create an account

When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.

DisagreeAgree

Notify of

new follow-up comments new replies to my comments

Label

{} [+]

Name*

Email*

Website

I allow to create an account

When you login first time using a Social Login button, we collect your account public profile information shared by Social Login provider, based on your privacy settings. We also get your email address to automatically create an account for you in our website. Once your account is created, you'll be logged-in to this account.

DisagreeAgree

Label

{} [+]

Name*

Email*

Website

0 Comments

Inline Feedbacks

View all comments